1. Home
  2. MRSN vs APWC Comparison

MRSN vs APWC Comparison

Compare MRSN & APWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • APWC
  • Stock Information
  • Founded
  • MRSN 2001
  • APWC 1996
  • Country
  • MRSN United States
  • APWC Taiwan
  • Employees
  • MRSN N/A
  • APWC N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • APWC Telecommunications Equipment
  • Sector
  • MRSN Health Care
  • APWC Industrials
  • Exchange
  • MRSN Nasdaq
  • APWC Nasdaq
  • Market Cap
  • MRSN 34.0M
  • APWC 38.1M
  • IPO Year
  • MRSN 2017
  • APWC 1997
  • Fundamental
  • Price
  • MRSN $6.75
  • APWC $1.83
  • Analyst Decision
  • MRSN Strong Buy
  • APWC
  • Analyst Count
  • MRSN 5
  • APWC 0
  • Target Price
  • MRSN $5.75
  • APWC N/A
  • AVG Volume (30 Days)
  • MRSN 130.5K
  • APWC 6.2K
  • Earning Date
  • MRSN 08-12-2025
  • APWC 08-25-2025
  • Dividend Yield
  • MRSN N/A
  • APWC N/A
  • EPS Growth
  • MRSN N/A
  • APWC N/A
  • EPS
  • MRSN N/A
  • APWC 0.17
  • Revenue
  • MRSN $34,006,000.00
  • APWC $472,672,000.00
  • Revenue This Year
  • MRSN N/A
  • APWC N/A
  • Revenue Next Year
  • MRSN $1.03
  • APWC N/A
  • P/E Ratio
  • MRSN N/A
  • APWC $10.94
  • Revenue Growth
  • MRSN N/A
  • APWC 11.02
  • 52 Week Low
  • MRSN $6.47
  • APWC $1.36
  • 52 Week High
  • MRSN $70.75
  • APWC $2.02
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 38.74
  • APWC 64.26
  • Support Level
  • MRSN $6.55
  • APWC $1.76
  • Resistance Level
  • MRSN $10.25
  • APWC $1.93
  • Average True Range (ATR)
  • MRSN 0.70
  • APWC 0.04
  • MACD
  • MRSN -0.20
  • APWC 0.01
  • Stochastic Oscillator
  • MRSN 5.41
  • APWC 64.29

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)

Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, PRC, Hong Kong and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.

Share on Social Networks: